newsfilter
← Latest News
Business Wire·

Statement in Response to News of the Indictment of Teva USA

TEL AVIV & PARSIPPANY, N.J.--(BUSINESS WIRE)--Today Teva Pharmaceutical Industries Ltd. (NYSE: and TASE: TEVA) is responding to news reports detailing that a federal grand jury in Philadelphia, Pennsylvania has returned a criminal indictment charging Teva USA with three counts of antitrust violations under the Sherman Act.